Neurosense Therapeutics Ltd. (NRSN) Cash flow

202 Followers

Neurosense Therapeutics Ltd. Cash Flow

NRSN's free cash flow for Q2 2025 was $-2.00K. For the 2025 fiscal year, NRSN's free cash flow was decreased by $2.46M and operating cash flow was $-2.00K. See a summary of the company’s cash flow.

Cash Flow	Mar 26	Mar 25	Mar 24	Dec 22	Dec 21
Operating Cash Flow	$ -7.67M	$ -10.13M	$ -8.35M	$ -7.59M	$ -1.54M
Investing Cash Flow	$ -8.00K	$ 1.00K	$ 3.47M	$ -3.54M	$ -17.00K
Financing Cash Flow	$ 4.43M	$ 10.91M	$ 3.98M	$ 3.69M	$ 11.90M
End Cash Position	$ 166.00K	$ 3.38M	$ 2.64M	$ 3.54M	$ 11.06M
Free Cash Flow	$ -7.68M	$ -10.14M	$ -8.38M	$ -7.66M	$ -1.56M

Currency in USD